Seeing How the Brain Changes During Aging

oup has also developed a radiotracer that monitors the level of an enzyme called MAO B that breaks down dopamine. Levels of MAO B increase as we age, contributing to dopamine deficiency. A drug called L-Deprenyl inhibits MAO B and is used to treat patients with Parkinson's and Alzheimer's disease. Fowler says that the PET studies suggest that if we can do things to enhance the activity of dopamine in the human brain, we may be able to slow down some of the cognitive and motor declines in aging and might be able to help determine what doses of the drug would be most beneficial to an individual.

Paper ORGN 4 will be presented by J. S. Fowler from 11:00 a.m. to 12:00 noon, Sun., March 29, in the Convention Center Ballroom A I, Level 3.

A nonprofit organization with a membership of more than 155,000 chemists and chemical engineers, the American Chemical Society publishes scientific journals, convenes major research conferences, and provides educational, science policy and career programs in chemistry. Its main offices are in Washington, D.C., and Columbus, Ohio.


Contact: Nancy Blount
American Chemical Society

Page: 1 2

Related biology news :

1. Seeing the forest for the trees: The future of environmental policy lies in interaction
2. Seeing how plants split water could provide key to our future energy needs
3. Seeing stars after LASIK? Study suggests certain pre-surgery factors may be to blame
4. Seeing one weapon from a food-borne pathogen
5. Seeing Blue-Yellow Color Perception For The First Time
6. The CIA Would Like To Know What Scientists Are Seeing Over The Rainbow
7. Brain has center for detecting sound motion
8. Brains reward circuitry revealed in procrastinating primates
9. Brain serotonin enzyme finding might explain psychiatric disorders
10. Brain development and puberty may be key factors in learning disorders
11. Organization for Human Brain Mapping 2004 Annual Meeting

Post Your Comments:

(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded ... of its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for ... fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
Breaking Biology Technology:
Cached News: